Genmab A/S announced the granting of 6,933 restricted stock units and 7,377 warrants to employees. Each unit is worth DKK 1,957, and vests after three years. The warrants, with an exercise price of DKK 1,957, expire seven years after grant. Genmab focuses on innovative antibody therapeutics to improve patient lives. For more information, visit their website. Contact Marisol Peron at [email protected] or Andrew Carlsen at [email protected] for inquiries. Refer to their most recent financial reports for risk factors. The company owns trademarks like Genmab and KYSO. Company announcement no. 52 provides more details.

Read more at GlobeNewswire: Grant of Restricted Stock Units and Warrants to Employees